Quantitative pharmacokinetic analysis of [18F]BCPP-EF in abdominal organs

A quantitative pharmacokinetic analysis of [18F]BCPP-EF in abdominal organs - BCPP-EF PK

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000061430

Enrollment

Registered

2026-05-11

Start date

2026-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Blood sampling, intravenous PET tracer injection, CT imaging, and PET imaging

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Individuals who are => 20 years old and < 70 years old at the time of informed consent acquisition (2) Individuals without a psychiatric or neurological history (3) Individuals without a smoking history (4) Individuals without alcoholics (5) Individuals not taking regular medicines (6) Capability of written informed consent based on their own decision

Exclusion criteria

Exclusion criteria: (1) Healthy subjects who have participated in another nuclear medicine study within the past year. (2) Pregnant, possibly pregnant or lactating women (3) Others judged inappropriate for the study by the investigator(s).

Design outcomes

Primary

Measure	Time frame
Correlation between [18F]BCPP-EF parametric images (including distribution volume) obtained from compartment model analysis and semiquantitative tracer uptake images.	—

Secondary

Measure	Time frame
Correlations between clinical, hematological, and imaging parameters	—

Countries

Japan

Contacts

Public ContactHiroyuki Ohba

Hamamatsu Photonics K.K. Central Research Laboratory

h-ohba@crl.hpk.co.jp053-586-7111

Outcome results